Table 4 Comparison of demographic and clinical data of patients by healthcare system
From: Psychosocial and economic impact of rheumatic diseases on caregivers of Mexican children
Total 200 n (%) | PartC 147 n (%) | FullC 43 n (%) | PRI 10 n (%) | P value* | ||
|---|---|---|---|---|---|---|
Age in years, median (IQR) | 13 (10–15) | 12 (9–15) | 14 (12–16) | 13.5 (10.7–15.2) | 0.01** | |
Female | 134 (67) | 95 (64.6) | 32 (74.4) | 7 (70) | 0.85 | |
Cutaneous symptoms | 82/193 (42.5) | 71/140 (50.7) | 8 (18.6) | 3 (30) | 0.01 | |
Musculoskeletal symptoms a | 161/193 (83.4) | 120/140 (85.7) | 32 (74.4) | 9 (90) | 0.19 | |
Systemic symptoms b | 62/193 (32.1) | 48/140 (34.3) | 11 (25.6) | 3 (30) | 0.56 | |
Treatment | NSAID | 80/179 (44.7) | 70/126 (55.6) | 3 (7) | 7 (70) | < 0.001 |
DMARD | 168/179 (93.9) | 122/126 (96.8) | 36 (83.7) | 10 (100) | 0.01 | |
Glucocorticoid | 82/179 (45.8) | 72/126 (57.1) | 7 (16.3) | 3 (30) | < 0.001 | |
bDMARD | 53/179 (29.6) | 24/126 (19) | 24 (55.8) | 5 (50) | < 0.001 | |
Hospitalization | 97/174 (55.7) | 77/121 (63.6) | 19 (44.2) | 1 (10) | 0.01 | |
Disability | 43/174 (24.7) | 41/121 (33.9) | 1 (2.3) | 1 (10) | < 0.001 | |
Active Disease | 87/174 (50) | 75/121 (62) | 8 (18.6) | 4 (40) | < 0.001 | |